Marina Mauro

Como, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Risk of Systemic Reactions After Repeated Large Local Reactions in Hymenoptera Venom Allergy: A Real-World Study.

Risk of Systemic Reactions After Repeated Large Local Reactions in Hymenoptera Venom Allergy: A Real-World Study.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: May 23, 2026

Safety of Venom Immunotherapy in Pregnancy: A Multicentre Study.

Safety of Venom Immunotherapy in Pregnancy: A Multicentre Study.

Journal: Allergy
Published: February 24, 2026

Depot Extracts for Venom Immunotherapy: A Delphi Consensus on Safety and Efficacy.

Depot Extracts for Venom Immunotherapy: A Delphi Consensus on Safety and Efficacy.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: January 21, 2026

Hypersensitivity Reactions to Gadolinium-Based Contrast Agents: Update From an Allergist's Point of View.

Hypersensitivity Reactions to Gadolinium-Based Contrast Agents: Update From an Allergist's Point of View.

Journal: Clinical and translational allergy
Published: April 02, 2025

Safety and efficacy of extended venom immunotherapy maintenance intervals in mastocytosis.

Safety and efficacy of extended venom immunotherapy maintenance intervals in mastocytosis.

Journal: The journal of allergy and clinical immunology. In practice
Published: December 30, 2024

Correction to: SIRM‑SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media.

Correction to: SIRM‑SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media.

Journal: Clinical and molecular allergy : CMA
Published: August 22, 2024

Quality of Life in Hymenoptera Venom Allergy: Minimal Clinically Important Difference for the Vespid Quality of Life Questionnaire.

Quality of Life in Hymenoptera Venom Allergy: Minimal Clinically Important Difference for the Vespid Quality of Life Questionnaire.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: May 23, 2024

Venom immunotherapy: safety and tolerability of the build-up phase with depot versus aqueous preparations.

Venom immunotherapy: safety and tolerability of the build-up phase with depot versus aqueous preparations.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: March 21, 2022

Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?

Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?

Journal: Frontiers in allergy
Published: January 13, 2022

β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy.

β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy.

Journal: Allergy
Published: November 18, 2020

Pregnancy and Hymenoptera venom allergy.

Pregnancy and Hymenoptera venom allergy.

Journal: Current opinion in allergy and clinical immunology
Published: August 10, 2020

Treating venom allergy during COVID-19 pandemic.

Treating venom allergy during COVID-19 pandemic.

Journal: Allergy
Published: May 10, 2020
Showing 1-12 of 34

Last Updated: 09/26/2026